Amanote Research

Amanote Research

    RegisterSign In

The Drug Raloxifene May Not Only Reverse Some of the Damage Done by Osteoporosis

Journal of the American Osteopathic Association, The - United States
doi 10.7556/jaoa.1997.97.7.386b
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineAlternative MedicineComplementary
Date

July 1, 1997

Authors

Unknown

Publisher

American Osteopathic Association


Related search

Peripheral Artery Disease and Osteoporosis: Not Only Age‑related (Review)

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Some Stage III Colon Cancer Patients May Need Only Half of the Standard Chemotherapy Course

Cancer
Cancer ResearchOncology
2017English

Crystal Structures of the Osteoporosis Drug Risedronate

Acta Crystallographica Section A Foundations of Crystallography
2007English

Not at the Expense of Osteoporosis Care

BMJ
2008English

Not Everything That Can Be Done Should Be Done

Local and Regional Anesthesia
AnesthesiologyPain Medicine
2016English

Human Medicines European Public Assessment Report (EPAR): Raloxifene Teva, Raloxifene, Osteoporosis, Postmenopausal, Date of Authorisation: 29/04/2010, Revision: 8, Status: Authorised

Case Medical Research
2019English

Decommunization: The Process Matters, Not Only the Result

City History, Culture, Society
2017English

MOFOID--not Only the Protein Modeling Server.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2005English

What Has Posterity Done for Us? It's Not the Point

Nature
Multidisciplinary
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy